Literature DB >> 26596217

Reciprocal contribution of Th17 and regulatory T cells in severe drug allergy.

Hideo Hashizume1, Toshiharu Fujiyama2, Yoshiki Tokura2.   

Abstract

Entities:  

Keywords:  CD4(+) T lymphocyte; Drug-induced hypersensitivity syndrome; Stevens–Johnson syndrome; Th17; Toxic epidermal necrolysis; Treg

Mesh：

Substances：

Year:  2015        PMID： 26596217     DOI： 10.1016/j.jdermsci.2015.11.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  6 in total

Review 1.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

Review 2.  Toxic epidermal necrolysis.

Authors:  Wolfram Hoetzenecker; Tarun Mehra; Ieva Saulite; Martin Glatz; Peter Schmid-Grendelmeier; Emmanuella Guenova; Antonio Cozzio; Lars E French
Journal:  F1000Res       Date:  2016-05-20

Review 3.  Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).

Authors:  Fumi Miyagawa; Hideo Asada
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 4.  The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.

Authors:  Yun-Shiuan Olivia Hsu; Kun-Lin Lu; Yun Fu; Chuang-Wei Wang; Chun-Wei Lu; Yu-Fen Lin; Wen-Cheng Chang; Kun-Yun Yeh; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 5.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

6.  Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis.

Authors:  Yin Zongyi; Chen Dongying; Li Baifeng
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.